Laura Starost
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Laura Starost has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
Tanja Kuhlmann
Institute of Neuropathology, University Hospital Münster, 48149 Münster, Germany
2 shared publications- Anne Baron-Van Evercooren
INSERM, U1127, F-75013 Paris, France
1 shared publication - Beatriz Garcia-Diaz
Sorbonne Université, Paris Brain Institute – Institut du Cerveau (ICM), Inserm, CNRS, Hôpital Pitié-Salpêtrière, F-75013 Paris, France
1 shared publication - Blandine Manot-Saillet
Université Paris Cité, Institute of Psychiatry and Neuroscience of Paris (IPNP), INSERM U1266, “Team: Interactions between neurons and oligodendroglia in myelination and myelin repair
1 shared publication - Christina Sergiou
Department of Neuropathology, University of Göttingen Medical Center, 37075 Göttingen, Germany
1 shared publication - Christine Stadelmann
Department of Neuropathology University Medical Center Göttingen Göttingen Germany
1 shared publication
Latest Publications
- Open Access
- 4 December 2020
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 6 (49) , eabc6983
Multiple sclerosis iPS-derived oligodendroglia conserve their properties to functionally interact with axons and glia in vivo
MS-derived oligodendrocytes conserve their ability to fully interact with axons and glial cells in vivo.
- 4 December 2020
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 6 (49) , eabc6983
Open AccessMultiple sclerosis iPS-derived oligodendroglia conserve their properties to functionally interact with axons and glia in vivo
MS-derived oligodendrocytes conserve their ability to fully interact with axons and glial cells in vivo.
- Top Cited Papers
- 6 December 2017
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 9 (419)
BCAS1 expression defines a population of early myelinating oligodendrocytes in multiple sclerosis lesions
Investigations into brain function and disease depend on the precise classification of neural cell types. Cells of the oligodendrocyte lineage differ greatly in their morphology, but accurate identification has thus far only been possible for oligodendrocyte progenitor cells and mature oligodendrocytes in humans. We find that breast carcinoma amplified sequence 1 (BCAS1) expression identifies an oligodendroglial subpopulation in the mouse and human brain. These cells are newly formed, myelinating oligodendrocytes that segregate from oligodendrocyte progenitor cells and mature oligodendrocytes and mark regions of active myelin formation in development and in the adult. We find that BCAS1+ oligodendrocytes are restricted to the fetal and early postnatal human white matter but remain in the cortical gray matter until old age. BCAS1+ oligodendrocytes are reformed after experimental demyelination and found in a proportion of chronic white matter lesions of patients with multiple sclerosis (MS) even in a subset of patients with advanced disease. Our work identifies a means to map ongoing myelin formation in health and disease and presents a potential cellular target for remyelination therapies in MS.
- 6 December 2017
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 9 (419)
Top Cited PapersBCAS1 expression defines a population of early myelinating oligodendrocytes in multiple sclerosis lesions
Investigations into brain function and disease depend on the precise classification of neural cell types. Cells of the oligodendrocyte lineage differ greatly in their morphology, but accurate identification has thus far only been possible for oligodendrocyte progenitor cells and mature oligodendrocytes in humans. We find that breast carcinoma amplified sequence 1 (BCAS1) expression identifies an oligodendroglial subpopulation in the mouse and human brain. These cells are newly formed, myelinating oligodendrocytes that segregate from oligodendrocyte progenitor cells and mature oligodendrocytes and mark regions of active myelin formation in development and in the adult. We find that BCAS1+ oligodendrocytes are restricted to the fetal and early postnatal human white matter but remain in the cortical gray matter until old age. BCAS1+ oligodendrocytes are reformed after experimental demyelination and found in a proportion of chronic white matter lesions of patients with multiple sclerosis (MS) even in a subset of patients with advanced disease. Our work identifies a means to map ongoing myelin formation in health and disease and presents a potential cellular target for remyelination therapies in MS.